Tech Company Financing Transactions
Sienna Biopharmaceuticals Funding Round
Arch Venture Partners, Altitude Life Science Ventures and Partner Fund Management participated in a $34 million Series A funding round for Sienna Biopharmaceuticals. The round was announced on 4/30/2016.
Transaction Overview
Arch Venture Partners (Lead Investor) (Robert Nelsen)
Company Information
Westlake Village, CA 91362
USA
Management Team
Browse more venture capital transactions:
Prev: 4/30/2016: nanit venture capital transaction
Next: 4/30/2016: FLX Bio venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs